Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a Comment in The Lancet Diabetes & Endocrinology , written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA.
http://ift.tt/1h60KcP
http://ift.tt/1h60KcP
No comments:
Post a Comment